Bright Path Applauds Presidential Proclamation Imposing Tariffs on Imported Pharmaceuticals
PR Newswire —
DARPA-validated company is already manufacturing essential medicine APIs entirely on U.S. soil MESA, Ariz., April 2, 2026 /PRNewswire/ -- Bright Path, a U.S.-based advanced pharmaceutical manufacturer, today welcomed President Trump's proclamation imposing tariffs of up to 100 percent on...